✦ LIBER ✦

P.3.c.052 Long-term efficacy and safety of bifeprunox in stable patients with schizophrenia: findings from a 6-month study

✍ Scribed by M. Bourin; M. Debelle; J. Heisterberg; M. Krog Josiassen; J. Buch Østergaard; E.A. Sands; P.P. Yeung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of bifeprunox in pat

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

P.3.c.006 Safety and efficacy of olanzap

✍ D.P. McDonnell; H.C. Detke; M. Choukour; J. Landry 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P.1.c.002 Long -term efficacy and safety

✍ L. Schmidt; J. Zarra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

P.3.c.046 Long-term safety and maintenan

✍ H. Meltzer; M. Cohen; L. Snow-Adami; M. Mackle; J. Zhao; A. Szegedi; J. Panagide 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 179 KB

P.2.013 Safety and efficacy of long-acti

✍ M. Cetin; S. Ebrinc; C. Basoglu; U.B. Semiz; H. Gunay; M.S. Iyisoy; B.M. Ergun; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Efficacy and safety of ustekinumab in Ja

✍ Atsuyuki IGARASHI; Takeshi KATO; Mai KATO; Michael SONG; Hidemi NAKAGAWA; THE JA 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB